Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Cantrell Drug Company
FDA Inspection
•Cantrell Drug Company•October 14, 2016

Cantrell Drug Company – FDA Inspection, Oct 14, 2016

Record Details

This FDA Inspection record concerns Cantrell Drug Company, with an inspection on October 14, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Cantrell Drug Company
Inspection Date
October 14, 2016
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Latorie S. Jones (FDA Associated Person)
  • Lisa R. Whitt (Issuing Officer)
  • Shelby N. Turner (Investigator)
View Company Profile

ID · 3d64491a-b19e-448f-a213-459743733749

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
990072
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

12
  1. 21 CFR 211.42(c)(10)(iii)Air Supply
  2. 21 CFR 211.42(c)(10)(v)Cleaning System
  3. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
  4. 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
  5. 21 CFR 211.113(b)Procedures for sterile drug products
  6. 21 CFR 211.42(c)(10)Aseptic Processing Area
  7. 21 CFR 211.165(a)Testing and release for distribution
  8. 21 CFR 211.167(a)Sterility/pyrogens - test methods written, followed
  9. 21 CFR 211.42(b)Adequate space lacking to prevent mix-ups and contamination
  10. FDCA 503B(a)(10)Drug product label, outsourcer facility

Showing 10 of 12 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Cantrell Drug Company

5
DateClassificationOfficeProject area
August 22, 2018VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
March 22, 2018OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
June 29, 2017OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 4, 2013OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
October 21, 2011NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Cantrell Drug Company
  • FDA Inspection 1062937 - 2018-08-22
  • FDA Inspection 1045988 - 2018-03-22
  • FDA Inspection 1016395 - 2017-06-29
  • FDA Inspection 853222 - 2013-11-04
  • FDA Inspection 751395 - 2011-10-21

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Cantrell Drug Company
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.